Exploring Acid-Base Imbalance in Liver Cirrhosis: Diagnostic and Therapeutic Perspectives
DOI:
https://doi.org/10.70749/ijbr.v3i5.1512Keywords:
Cirrhosis, Acid-base imbalance, Respiratory alkalosis, Metabolic acidosisAbstract
Background: liver cirrhosis Patients experience disturbances in their body acid-base balance which reflects disease of the liver and affect the whole body. Possible imbalances can be either metabolic alkalosis, respiratory alkalosis or high anion gap metabolic acidosis and each can provide valuable diagnostic and outcome insights. Objectives: To explore the processes, patterns and clinical outcomes of acid-base disorders in patients with cirrhosis and to suggest relevant diagnostic and treatment methods. Study Design: A Cross-Sectional Study. Place and Duration of study: From July 2024 to December 2024 Gastroenterology Department, Sandeman Provincial Hospital / Bolan Medical College / Hospital, Quetta. Methods: This cross-sectional study conducted at a tertiary Hospital between July 2024 to December 2024. We obtained the data from cirrhotic patients who had blood analyzed in an arterial blood gas test. Results: 94 cirrhotic patients investigated (mean age: 54.7 ± 9.6) years), 82.9% had acid-base disorders. A typical finding in our cohort was respiratory alkalosis which was seen in 46.8% of all patients and mainly related to hepatic encephalopathy or portosystemic shunting. In 17.0% of these patients, metabolic alkalosis took place, commonly seen in those who use a lot of diuretics and lose stomach fluids through vomiting. The majority of cases of high anion gap metabolic acidosis (11.7%) were found in patients with advanced liver failure, sepsis or trouble with kidney function 4% of the cases were mixed acid-base disorders. Marked hypoalbuminemia was found in nearly all cases (88%) which meant that albumin-corrected anion gap was used to accurately understand metabolic acidosis and enhance diagnostic precision. Conclusion: Irregular acid-base levels are typical in cirrhosis and often occur together. Correctly uncovering liver and kidney problems and using management based on these issues is necessary to improve these patients’ outcomes.
Downloads
References
Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 2020. Hepatology. 2020;35(3):716-721.
https://doi.org/10.1053/jhep.2002.31250
Bernardi M, Moreau R, Angeli P, et al. Mechanisms of decompensation and organ failure in cirrhosis: the role of systemic inflammation. J Hepatol. 2015;63(4):1038-1046.
https://doi.org/10.1016/j.jhep.2015.07.004
Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2012;36(1):227-242.
https://doi.org/10.1053/jhep.2002.34734
Wright G, Jalan R. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology. 2017;46(2):291-294.
https://doi.org/10.1002/hep.21843
Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2020;361(13):1279-1290.
https://doi.org/10.1056/nejmra0809139
O'Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (ACLF) score predicts mortality in hospitalized patients with cirrhosis. Hepatology. 2018;67(6):2367-2374.
https://doi.org/10.1002/hep.29773
Kumar R, Shalimar, Bhatia V, et al. Evaluation of an albumin-corrected anion gap in patients with liver cirrhosis: a prospective study. J Clin Exp Hepatol. 2019;9(3):287-292.
Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N Engl J Med. 2021;384(24):2317-2330.
https://doi.org/10.1056/nejmra2021808
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;362:k2817.
https://doi.org/10.1136/bmj.k2817
Singh V, Sharma AK, Dheerendra PC, et al. Terlipressin versus albumin in the treatment of type 1 hepatorenal syndrome: a randomized controlled study. J Hepatol. 2012;56(1):129-136.
https://doi.org/10.1016/j.jhep.2012.01.012
Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968-974.
https://doi.org/10.1016/j.jhep.2014.12.029
Wright G, Davies NA, Shawcross DL, et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats. Hepatology. 2007;45(6):1517-1526.
https://doi.org/10.1002/hep.21599
Davenport A, Sheikh MF, Lamb E, Agarwal B. The importance of correcting the anion gap for hypoalbuminaemia in critically ill patients. Intensive Care Med. 2012;38(2):329-330.
Wrenn KD, Slovis CM, Slovis BS. The significance of the serum anion gap in the evaluation of acid-base disorders. JAMA. 1990;263(2):241-244.
https://doi.org/10.1016/s0196-0644(05)82194-8
Bernardi M, Ricci CS, Zaccherini G. Role of human albumin in the management of complications of liver cirrhosis. J Clin Exp Hepatol. 2014;4(4):302-311.
https://doi.org/10.1016/j.jceh.2014.08.007
Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279-1290.
Wright G, Jalan R. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology. 2007;46(2):291-294.
https://doi.org/10.1002/hep.21843
Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2019;361(13):1279-1290.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
